| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylethanolamine binding | 5.54e-08 | 19 | 112 | 5 | GO:0008429 | |
| GeneOntologyMolecularFunction | NAD+ nucleosidase activity | 3.64e-05 | 12 | 112 | 3 | GO:0003953 | |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 9.12e-05 | 16 | 112 | 3 | GO:0061809 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | A2M RGPD4 DENND5B RASGRF1 HACD3 OBSCN APOH NEK9 KAT2B ABCE1 RGPD3 PLCB1 FGF13 C5 DENND5A BSN MAPK8 ARHGAP20 GCN1 IQGAP3 | 1.11e-04 | 1418 | 112 | 20 | GO:0030234 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CACNB2 OBSCN GABARAP SAXO2 MAP1LC3A SORBS1 TUBGCP4 GABARAPL1 MAP1LC3B2 ARC FGF13 MAP1LC3B MAPK8 PLS1 IQGAP3 SNTB2 | 4.14e-04 | 1099 | 112 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 DENND5B RASGRF1 HACD3 OBSCN RGPD3 PLCB1 DENND5A ARHGAP20 IQGAP3 | 5.70e-04 | 507 | 112 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 DENND5B RASGRF1 HACD3 OBSCN RGPD3 PLCB1 DENND5A ARHGAP20 IQGAP3 | 5.70e-04 | 507 | 112 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 8.54e-04 | 8 | 112 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | interleukin-1 receptor activity | 8.54e-04 | 8 | 112 | 2 | GO:0004908 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 8.54e-04 | 8 | 112 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | GTPase binding | 9.64e-04 | 360 | 112 | 8 | GO:0051020 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | EPRS1 DIS3L IARS1 SMARCAL1 POLRMT RECQL5 DDX54 TOP1MT TOP2B MOV10 HELLS | 1.00e-03 | 645 | 112 | 11 | GO:0140640 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.09e-03 | 9 | 112 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.09e-03 | 9 | 112 | 2 | GO:0099626 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen levels | 3.17e-09 | 12 | 111 | 5 | GO:0043562 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen starvation | 3.17e-09 | 12 | 111 | 5 | GO:0006995 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient levels | DAPL1 CYP27B1 GABARAP MAP1LC3A MAP3K5 KAT2B GABARAPL1 MAP1LC3B2 ALB MAP1LC3B MAPK8 GCN1 | 1.78e-08 | 262 | 111 | 12 | GO:0031669 |
| GeneOntologyBiologicalProcess | cellular response to starvation | DAPL1 GABARAP MAP1LC3A MAP3K5 GABARAPL1 MAP1LC3B2 ALB MAP1LC3B MAPK8 GCN1 | 6.22e-08 | 185 | 111 | 10 | GO:0009267 |
| GeneOntologyBiologicalProcess | response to nutrient levels | A2M DAPL1 CYP27B1 GABARAP MAP1LC3A MAP3K5 KAT2B GABARAPL1 MAP1LC3B2 AACS ALB MAP1LC3B MAPK8 GCN1 CNR1 | 3.76e-07 | 566 | 111 | 15 | GO:0031667 |
| GeneOntologyBiologicalProcess | response to starvation | DAPL1 GABARAP MAP1LC3A MAP3K5 GABARAPL1 MAP1LC3B2 ALB MAP1LC3B MAPK8 GCN1 | 4.53e-07 | 229 | 111 | 10 | GO:0042594 |
| GeneOntologyBiologicalProcess | organelle disassembly | ATG2B GABARAP MAP1LC3A GABARAPL1 MAP1LC3B2 ABCE1 LRBA MAP1LC3B GCN1 | 1.61e-06 | 204 | 111 | 9 | GO:1903008 |
| GeneOntologyBiologicalProcess | autophagy of mitochondrion | 2.77e-06 | 114 | 111 | 7 | GO:0000422 | |
| GeneOntologyBiologicalProcess | autophagosome assembly | 4.12e-06 | 121 | 111 | 7 | GO:0000045 | |
| GeneOntologyBiologicalProcess | autophagosome organization | 6.29e-06 | 129 | 111 | 7 | GO:1905037 | |
| GeneOntologyBiologicalProcess | cellular response to amino acid starvation | 1.27e-05 | 56 | 111 | 5 | GO:0034198 | |
| GeneOntologyBiologicalProcess | response to amino acid starvation | 1.93e-05 | 61 | 111 | 5 | GO:1990928 | |
| GeneOntologyBiologicalProcess | autophagosome maturation | 3.52e-05 | 69 | 111 | 5 | GO:0097352 | |
| GeneOntologyBiologicalProcess | synaptic signaling | CACNB2 PDE9A RASGRF1 APBA2 GABARAP SORBS1 SLC38A1 IL1RAPL1 EIF4E PLCB1 ARC RIMBP2 BSN MAPK8 IL1RAP CNR1 | 6.67e-05 | 976 | 111 | 16 | GO:0099536 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CACNB2 PDE9A RASGRF1 APBA2 GABARAP SLC38A1 IL1RAPL1 EIF4E PLCB1 ARC RIMBP2 BSN MAPK8 IL1RAP CNR1 | 1.53e-04 | 939 | 111 | 15 | GO:0099537 |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 1.88e-04 | 21 | 111 | 3 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 1.88e-04 | 21 | 111 | 3 | GO:0002501 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-glucose deprivation | 2.84e-04 | 5 | 111 | 2 | GO:0090650 | |
| GeneOntologyCellularComponent | autolysosome | 2.42e-06 | 18 | 114 | 4 | GO:0044754 | |
| GeneOntologyCellularComponent | secondary lysosome | 1.14e-05 | 26 | 114 | 4 | GO:0005767 | |
| GeneOntologyCellularComponent | autophagosome membrane | 1.47e-05 | 57 | 114 | 5 | GO:0000421 | |
| GeneOntologyCellularComponent | cytoplasmic region | GABARAP SAXO2 AK8 GABARAPL1 MAP1LC3B2 ARC RIMBP2 MAP1LC3B BSN MAPK8 | 2.82e-05 | 360 | 114 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 3.86e-05 | 35 | 114 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | GABARAP SAXO2 AK8 GABARAPL1 MAP1LC3B2 ARC MAP1LC3B BSN MAPK8 | 6.09e-05 | 317 | 114 | 9 | GO:0032838 |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.36e-04 | 48 | 114 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | autophagosome | 4.92e-04 | 119 | 114 | 5 | GO:0005776 | |
| GeneOntologyCellularComponent | membrane attack complex | 6.08e-04 | 7 | 114 | 2 | GO:0005579 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 8.08e-04 | 8 | 114 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | cell cortex | 9.81e-04 | 371 | 114 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.29e-03 | 10 | 114 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | trans-Golgi network | 1.46e-03 | 306 | 114 | 7 | GO:0005802 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MAP1LC3A IL1RAPL1 NSG2 EIF4E PRICKLE2 PLCB1 ARC RIMBP2 BSN IL1RAP CDH6 CNR1 | 1.68e-03 | 817 | 114 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | vacuolar membrane | HLA-DRB1 HLA-DRB4 GABARAP MAP1LC3A SPPL2A GABARAPL1 MAP1LC3B2 LRBA MAP1LC3B | 1.85e-03 | 507 | 114 | 9 | GO:0005774 |
| GeneOntologyCellularComponent | supramolecular fiber | HLA-DRB1 OBSCN GABARAP SAXO2 MAP1LC3A TUBGCP4 PPL KAT2B GABARAPL1 MAP1LC3B2 FGF13 MAP1LC3B PLS1 SNTB2 AHNAK2 | 1.86e-03 | 1179 | 114 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | aminoacyl-tRNA synthetase multienzyme complex | 1.88e-03 | 12 | 114 | 2 | GO:0017101 | |
| GeneOntologyCellularComponent | supramolecular polymer | HLA-DRB1 OBSCN GABARAP SAXO2 MAP1LC3A TUBGCP4 PPL KAT2B GABARAPL1 MAP1LC3B2 FGF13 MAP1LC3B PLS1 SNTB2 AHNAK2 | 1.99e-03 | 1187 | 114 | 15 | GO:0099081 |
| GeneOntologyCellularComponent | dendrite | RASGRF1 APBA2 IL1RAPL1 GABARAPL1 NSG2 MAP1LC3B2 ARC ROBO1 FGF13 MAP1LC3B BSN MAPK8 | 2.52e-03 | 858 | 114 | 12 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | RASGRF1 APBA2 IL1RAPL1 GABARAPL1 NSG2 MAP1LC3B2 ARC ROBO1 FGF13 MAP1LC3B BSN MAPK8 | 2.57e-03 | 860 | 114 | 12 | GO:0097447 |
| GeneOntologyCellularComponent | annulate lamellae | 2.57e-03 | 14 | 114 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | microtubule | GABARAP SAXO2 MAP1LC3A TUBGCP4 GABARAPL1 MAP1LC3B2 FGF13 MAP1LC3B SNTB2 | 2.59e-03 | 533 | 114 | 9 | GO:0005874 |
| HumanPheno | Abnormality of humoral immunity | HYOU1 HLA-DRB1 SMARCAL1 CASP10 SLC46A1 SPPL2A MTHFD1 ALB C5 LRBA C8B HELLS | 1.27e-06 | 350 | 34 | 12 | HP:0005368 |
| HumanPheno | Abnormal B cell morphology | HYOU1 HLA-DRB1 SMARCAL1 CASP10 SLC46A1 SPPL2A MTHFD1 ALB C5 LRBA C8B HELLS | 2.10e-06 | 367 | 34 | 12 | HP:0002846 |
| HumanPheno | Immunoglobulin abnormality | HYOU1 HLA-DRB1 SMARCAL1 CASP10 SLC46A1 SPPL2A MTHFD1 ALB LRBA HELLS | 1.38e-05 | 295 | 34 | 10 | HP:0100032 |
| HumanPheno | Abnormal circulating immunoglobulin concentration | HYOU1 HLA-DRB1 SMARCAL1 CASP10 SLC46A1 SPPL2A MTHFD1 ALB LRBA HELLS | 1.38e-05 | 295 | 34 | 10 | HP:0010701 |
| HumanPheno | Abnormality of B cell physiology | HYOU1 HLA-DRB1 SMARCAL1 CASP10 SLC46A1 SPPL2A MTHFD1 ALB LRBA HELLS | 1.42e-05 | 296 | 34 | 10 | HP:0005372 |
| HumanPheno | Abnormal lymphocyte morphology | HYOU1 HLA-DRB1 SMARCAL1 CASP10 SLC46A1 SPPL2A SF3B1 MTHFD1 ALB C5 LRBA C8B HELLS | 1.51e-05 | 524 | 34 | 13 | HP:0004332 |
| HumanPheno | Abnormal lymphocyte physiology | HYOU1 HLA-DRB1 SMARCAL1 CASP10 SLC46A1 SPPL2A MTHFD1 ALB LRBA HELLS | 3.48e-05 | 328 | 34 | 10 | HP:0031409 |
| HumanPheno | Abnormal leukocyte physiology | HYOU1 HLA-DRB1 SMARCAL1 CASP10 SLC46A1 SPPL2A MTHFD1 ALB LRBA HELLS | 3.48e-05 | 328 | 34 | 10 | HP:0033796 |
| HumanPheno | Abnormal immunological laboratory finding | HYOU1 HLA-DRB1 SMARCAL1 CASP10 SLC46A1 SPPL2A MTHFD1 ALB LRBA HELLS | 7.04e-05 | 356 | 34 | 10 | HP:0003346 |
| HumanPheno | Decreased circulating antibody concentration | 8.31e-05 | 224 | 34 | 8 | HP:0004313 | |
| HumanPheno | Abnormality of multiple cell lineages in the bone marrow | 1.47e-04 | 180 | 34 | 7 | HP:0012145 | |
| HumanPheno | Abnormal granulocyte morphology | HLA-DRB1 SMARCAL1 CASP10 SLC46A1 SPPL2A SF3B1 MTHFD1 LRBA HELLS | 1.64e-04 | 317 | 34 | 9 | HP:0001911 |
| HumanPheno | Pancytopenia | 1.76e-04 | 129 | 34 | 6 | HP:0001876 | |
| HumanPheno | Abnormal lymphocyte count | HYOU1 HLA-DRB1 SMARCAL1 CASP10 SLC46A1 SF3B1 MTHFD1 LRBA HELLS | 1.89e-04 | 323 | 34 | 9 | HP:0040088 |
| HumanPheno | Cellular metachromasia | 1.92e-04 | 131 | 34 | 6 | HP:0003653 | |
| HumanPheno | Abnormal cellular immune system morphology | HYOU1 HLA-DRB1 SMARCAL1 CYP27B1 CASP10 SLC46A1 SPPL2A SF3B1 MTHFD1 ALB C5 LRBA C8B HELLS | 2.22e-04 | 774 | 34 | 14 | HP:0010987 |
| HumanPheno | Abnormal leukocyte morphology | HYOU1 HLA-DRB1 SMARCAL1 CYP27B1 CASP10 SLC46A1 SPPL2A SF3B1 MTHFD1 ALB C5 LRBA C8B HELLS | 2.22e-04 | 774 | 34 | 14 | HP:0001881 |
| HumanPheno | Abnormality of neutrophils | 2.97e-04 | 269 | 34 | 8 | HP:0001874 | |
| HumanPheno | Abnormal immune system morphology | HYOU1 HLA-DRB1 SMARCAL1 CYP27B1 CASP10 SLC46A1 SPPL2A SF3B1 MTHFD1 ALB C5 LRBA C8B HELLS | 3.08e-04 | 798 | 34 | 14 | HP:0032251 |
| HumanPheno | Abnormal myeloid leukocyte morphology | HLA-DRB1 SMARCAL1 CASP10 SLC46A1 SPPL2A SF3B1 MTHFD1 LRBA HELLS | 3.18e-04 | 346 | 34 | 9 | HP:0010974 |
| HumanPheno | Increased circulating globulin level | 4.27e-04 | 5 | 34 | 2 | HP:0032311 | |
| HumanPheno | Increased alpha-globulin | 4.27e-04 | 5 | 34 | 2 | HP:0005413 | |
| HumanPheno | Abnormality of glycosaminoglycan metabolism | 4.31e-04 | 152 | 34 | 6 | HP:0004371 | |
| HumanPheno | Abnormality of mucopolysaccharide metabolism | 4.31e-04 | 152 | 34 | 6 | HP:0011020 | |
| HumanPheno | Abnormal circulating polysaccharide concentration | 4.31e-04 | 152 | 34 | 6 | HP:0011012 | |
| HumanPheno | Lymphopenia | 4.51e-04 | 286 | 34 | 8 | HP:0001888 | |
| HumanPheno | Abnormality of cells of the lymphoid lineage | 5.81e-04 | 297 | 34 | 8 | HP:0012140 | |
| HumanPheno | Decreased circulating terminal complement component concentration | 6.38e-04 | 6 | 34 | 2 | HP:0033057 | |
| Domain | Atg8 | 4.47e-10 | 8 | 115 | 5 | PF02991 | |
| Domain | Atg8-like | 4.47e-10 | 8 | 115 | 5 | IPR004241 | |
| Domain | Ubiquitin-rel_dom | UBTD2 GABARAP MAP1LC3A GABARAPL1 MAP1LC3B2 OASL MAP1LC3B ARHGAP20 | 1.84e-05 | 184 | 115 | 8 | IPR029071 |
| Domain | IL-1_rcpt_fam | 3.62e-05 | 11 | 115 | 3 | IPR015621 | |
| Domain | Ig-like_fold | SLAMF8 HLA-DRB1 HLA-DRB4 OBSCN IL1RL2 TGM5 IFNAR1 IL1RAPL1 HMCN1 NTM ROBO1 RIMBP2 IL1RAP TAPBP | 1.12e-04 | 706 | 115 | 14 | IPR013783 |
| Domain | - | HLA-DRB1 HLA-DRB4 OBSCN IL1RL2 TGM5 IFNAR1 IL1RAPL1 HMCN1 NTM ROBO1 RIMBP2 IL1RAP TAPBP | 2.22e-04 | 663 | 115 | 13 | 2.60.40.10 |
| Domain | IG_LIKE | SLAMF8 HLA-DRB1 HLA-DRB4 OBSCN IL1RL2 IL1RAPL1 HMCN1 NTM ROBO1 IL1RAP TAPBP | 2.25e-04 | 491 | 115 | 11 | PS50835 |
| Domain | Ig-like_dom | SLAMF8 HLA-DRB1 HLA-DRB4 OBSCN IL1RL2 IL1RAPL1 HMCN1 NTM ROBO1 IL1RAP TAPBP | 2.77e-04 | 503 | 115 | 11 | IPR007110 |
| Domain | TIR | 2.79e-04 | 21 | 115 | 3 | SM00255 | |
| Domain | PH_dom-like | RGPD4 RASGRF1 OBSCN APBA2 MTMR6 RGPD3 PLCB1 LRBA ARHGAP20 SNTB2 | 3.03e-04 | 426 | 115 | 10 | IPR011993 |
| Domain | TIR | 3.22e-04 | 22 | 115 | 3 | PF01582 | |
| Domain | - | 3.68e-04 | 23 | 115 | 3 | 3.40.50.10140 | |
| Domain | TIR | 4.19e-04 | 24 | 115 | 3 | PS50104 | |
| Domain | TIR_dom | 4.74e-04 | 25 | 115 | 3 | IPR000157 | |
| Domain | IL-1_rcpt_I/II-typ | 5.55e-04 | 6 | 115 | 2 | IPR004074 | |
| Domain | Rab_bind | 7.74e-04 | 7 | 115 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 7.74e-04 | 7 | 115 | 2 | IPR032023 | |
| Domain | MHC_II_b_N | 1.03e-03 | 8 | 115 | 2 | PD000328 | |
| Domain | A2M_N_2 | 1.03e-03 | 8 | 115 | 2 | SM01359 | |
| Domain | - | 1.03e-03 | 8 | 115 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 1.03e-03 | 8 | 115 | 2 | SM01361 | |
| Domain | A2M | 1.03e-03 | 8 | 115 | 2 | SM01360 | |
| Domain | MHC_II_b_N | 1.32e-03 | 9 | 115 | 2 | IPR000353 | |
| Domain | MHC_II_beta | 1.32e-03 | 9 | 115 | 2 | SM00921 | |
| Domain | MHC_II_beta | 1.32e-03 | 9 | 115 | 2 | PF00969 | |
| Domain | A2M | 1.64e-03 | 10 | 115 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.64e-03 | 10 | 115 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.64e-03 | 10 | 115 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.64e-03 | 10 | 115 | 2 | PF07677 | |
| Domain | A2M_comp | 1.64e-03 | 10 | 115 | 2 | PF07678 | |
| Domain | A2M_N | 1.64e-03 | 10 | 115 | 2 | PF01835 | |
| Domain | A2M_N | 1.64e-03 | 10 | 115 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.64e-03 | 10 | 115 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.64e-03 | 10 | 115 | 2 | PS00477 | |
| Domain | A2M_N_2 | 1.64e-03 | 10 | 115 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.64e-03 | 10 | 115 | 2 | IPR001599 | |
| Domain | - | 1.64e-03 | 10 | 115 | 2 | 1.10.220.60 | |
| Domain | Grip | 1.99e-03 | 11 | 115 | 2 | SM00755 | |
| Domain | GRIP | 1.99e-03 | 11 | 115 | 2 | PF01465 | |
| Domain | Ran_BP1 | 2.38e-03 | 12 | 115 | 2 | PF00638 | |
| Domain | RANBD1 | 2.38e-03 | 12 | 115 | 2 | PS50196 | |
| Domain | GRIP_dom | 2.38e-03 | 12 | 115 | 2 | IPR000237 | |
| Domain | GRIP | 2.38e-03 | 12 | 115 | 2 | PS50913 | |
| Domain | - | 2.38e-03 | 12 | 115 | 2 | 1.50.10.20 | |
| Domain | RanBD | 2.80e-03 | 13 | 115 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 2.80e-03 | 13 | 115 | 2 | IPR000156 | |
| Domain | MHC_II_a/b_N | 3.26e-03 | 14 | 115 | 2 | IPR014745 | |
| Domain | uDENN | 3.26e-03 | 14 | 115 | 2 | SM00800 | |
| Domain | - | 3.26e-03 | 14 | 115 | 2 | 3.10.320.10 | |
| Domain | uDENN | 3.74e-03 | 15 | 115 | 2 | PF03456 | |
| Domain | DENN | 4.26e-03 | 16 | 115 | 2 | SM00799 | |
| Domain | DENN | 4.26e-03 | 16 | 115 | 2 | PF02141 | |
| Domain | dDENN | 4.26e-03 | 16 | 115 | 2 | PF03455 | |
| Domain | UDENN | 4.26e-03 | 16 | 115 | 2 | PS50946 | |
| Domain | DDENN | 4.26e-03 | 16 | 115 | 2 | PS50947 | |
| Domain | dDENN | 4.26e-03 | 16 | 115 | 2 | SM00801 | |
| Domain | dDENN_dom | 4.26e-03 | 16 | 115 | 2 | IPR005112 | |
| Domain | uDENN_dom | 4.26e-03 | 16 | 115 | 2 | IPR005113 | |
| Domain | DENN | 4.26e-03 | 16 | 115 | 2 | PS50211 | |
| Domain | DENN_dom | 4.26e-03 | 16 | 115 | 2 | IPR001194 | |
| Domain | Helicase_C | 4.33e-03 | 107 | 115 | 4 | PF00271 | |
| Domain | HELICc | 4.33e-03 | 107 | 115 | 4 | SM00490 | |
| Domain | Helicase_C | 4.47e-03 | 108 | 115 | 4 | IPR001650 | |
| Domain | C1-set | 4.49e-03 | 54 | 115 | 3 | PF07654 | |
| Domain | HELICASE_CTER | 4.62e-03 | 109 | 115 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.62e-03 | 109 | 115 | 4 | PS51192 | |
| Domain | DEXDc | 4.62e-03 | 109 | 115 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.77e-03 | 110 | 115 | 4 | IPR014001 | |
| Domain | RUN | 5.39e-03 | 18 | 115 | 2 | SM00593 | |
| Domain | aa-tRNA-synth_I_CS | 5.39e-03 | 18 | 115 | 2 | IPR001412 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 5.39e-03 | 18 | 115 | 2 | IPR008930 | |
| Domain | Ig_C1-set | 5.49e-03 | 58 | 115 | 3 | IPR003597 | |
| Domain | RUN | 6.00e-03 | 19 | 115 | 2 | PS50826 | |
| Domain | RUN | 6.00e-03 | 19 | 115 | 2 | PF02759 | |
| Domain | Run_dom | 6.00e-03 | 19 | 115 | 2 | IPR004012 | |
| Domain | AA_TRNA_LIGASE_I | 6.00e-03 | 19 | 115 | 2 | PS00178 | |
| Domain | IG_MHC | 6.03e-03 | 60 | 115 | 3 | PS00290 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR_GRASP55 | 5.66e-06 | 6 | 94 | 3 | M47979 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION | 3.33e-05 | 10 | 94 | 3 | M47745 | |
| Pathway | REACTOME_RECEPTOR_MEDIATED_MITOPHAGY | 6.05e-05 | 12 | 94 | 3 | MM15525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_LC3_II_FORMATION | 7.82e-05 | 13 | 94 | 3 | M47458 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_P62_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION | 7.82e-05 | 13 | 94 | 3 | M47744 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR | 9.91e-05 | 14 | 94 | 3 | M47975 | |
| Pathway | WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION | 1.51e-04 | 16 | 94 | 3 | M48107 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR | 1.51e-04 | 16 | 94 | 3 | M47978 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION | 1.82e-04 | 17 | 94 | 3 | M47742 | |
| Pubmed | Essential role for GABARAP autophagy proteins in interferon-inducible GTPase-mediated host defense. | 2.10e-11 | 8 | 116 | 5 | 28604719 | |
| Pubmed | 2.94e-10 | 12 | 116 | 5 | 20577052 | ||
| Pubmed | 1.75e-09 | 6 | 116 | 4 | 24747438 | ||
| Pubmed | MAPK15/ERK8 stimulates autophagy by interacting with LC3 and GABARAP proteins. | 1.75e-09 | 6 | 116 | 4 | 22948227 | |
| Pubmed | 1.75e-09 | 6 | 116 | 4 | 17580304 | ||
| Pubmed | 4.08e-09 | 7 | 116 | 4 | 34929165 | ||
| Pubmed | Autophagy receptor NDP52 regulates pathogen-containing autophagosome maturation. | 8.14e-09 | 8 | 116 | 4 | 25771791 | |
| Pubmed | 8.14e-09 | 8 | 116 | 4 | 31685529 | ||
| Pubmed | 8.14e-09 | 8 | 116 | 4 | 31971854 | ||
| Pubmed | 8.14e-09 | 8 | 116 | 4 | 22470510 | ||
| Pubmed | Regulation of endoplasmic reticulum turnover by selective autophagy. | 1.46e-08 | 9 | 116 | 4 | 26040720 | |
| Pubmed | 1.46e-08 | 9 | 116 | 4 | 26524528 | ||
| Pubmed | Potent and specific Atg8-targeting autophagy inhibitory peptides from giant ankyrins. | 1.46e-08 | 9 | 116 | 4 | 29867141 | |
| Pubmed | Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. | 1.46e-08 | 9 | 116 | 4 | 21617041 | |
| Pubmed | 1.46e-08 | 9 | 116 | 4 | 29251248 | ||
| Pubmed | Nix is a selective autophagy receptor for mitochondrial clearance. | 2.43e-08 | 10 | 116 | 4 | 20010802 | |
| Pubmed | A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. | 2.43e-08 | 10 | 116 | 4 | 19250911 | |
| Pubmed | The IAP family member BRUCE regulates autophagosome-lysosome fusion. | 2.43e-08 | 10 | 116 | 4 | 29426817 | |
| Pubmed | 2.43e-08 | 10 | 116 | 4 | 30217973 | ||
| Pubmed | 2.43e-08 | 10 | 116 | 4 | 28287329 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | EPRS1 HACD3 IARS1 ATG2B MTHFD1 DDX54 GCN1 TAPBP TOP2B AHNAK2 | 2.49e-08 | 268 | 116 | 10 | 33024031 |
| Pubmed | HACD3 USP11 ATG2B POLRMT GABARAP MAP1LC3A NEK9 MAP3K5 RIF1 GABARAPL1 MAP1LC3B GCN1 | 2.82e-08 | 437 | 116 | 12 | 20562859 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 18069693 | ||
| Pubmed | Arginine68 is an essential residue for the C-terminal cleavage of human Atg8 family proteins. | 3.62e-08 | 3 | 116 | 3 | 23721406 | |
| Pubmed | Microtubule-Associated Protein 1 Light Chain 3 (LC3) Isoforms in RPE and Retina. | 3.62e-08 | 3 | 116 | 3 | 29721994 | |
| Pubmed | The DNA methyltransferase DNMT3A contributes to autophagy long-term memory. | 3.81e-08 | 11 | 116 | 4 | 32876528 | |
| Pubmed | 3.81e-08 | 11 | 116 | 4 | 23043107 | ||
| Pubmed | Methods for Studying Interactions Between Atg8/LC3/GABARAP and LIR-Containing Proteins. | 3.81e-08 | 11 | 116 | 4 | 28253953 | |
| Pubmed | Multiple roles of integrin-α3 at the neuromuscular junction. | 5.70e-08 | 12 | 116 | 4 | 28386022 | |
| Pubmed | 1.15e-07 | 14 | 116 | 4 | 31857374 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 23149744 | ||
| Pubmed | Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. | 1.44e-07 | 4 | 116 | 3 | 22267086 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 25301234 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 30633346 | ||
| Pubmed | Autophagic compartments gain access to the MHC class II compartments in thymic epithelium. | 1.44e-07 | 4 | 116 | 3 | 19915056 | |
| Pubmed | CCT2 is an aggrephagy receptor for clearance of solid protein aggregates. | 1.56e-07 | 15 | 116 | 4 | 35366418 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | OR51A4 EPRS1 HACD3 IARS1 NEXMIF OBSCN MTHFD1 ABCE1 CSNK1G2 EIF4E PRICKLE2 ALB ARHGAP20 PLS1 | 1.77e-07 | 736 | 116 | 14 | 29676528 |
| Pubmed | RGPD4 EPRS1 HACD3 IARS1 ATG2B APBA2 CPZ SORBS1 PDXK SF3B1 MTHFD1 ABCE1 RGPD3 PRICKLE2 PLCB1 BSN GCN1 | 2.47e-07 | 1139 | 116 | 17 | 36417873 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 HYOU1 HACD3 IARS1 POLRMT NEK9 PDXK SLC38A1 RIF1 SF3B1 MTHFD1 ABCE1 EIF4E DDX54 BSN GCN1 IQGAP3 TOP2B HELLS | 2.55e-07 | 1425 | 116 | 19 | 30948266 |
| Pubmed | A2M EPRS1 HYOU1 LONP2 POLRMT FBRSL1 TUBGCP4 ZC3H4 ABCE1 AACS DENND5A IQGAP3 HELLS | 2.85e-07 | 650 | 116 | 13 | 38777146 | |
| Pubmed | 3.03e-07 | 131 | 116 | 7 | 31006538 | ||
| Pubmed | TDRD15 AK8 PPL SLC38A1 RIF1 FAT1 SF3B1 MTHFD1 ZC3H4 ROBO1 ALB LRBA GCN1 HELLS | 3.40e-07 | 777 | 116 | 14 | 35844135 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 25227738 | ||
| Pubmed | TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. | 4.38e-07 | 19 | 116 | 4 | 26347139 | |
| Pubmed | TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. | 5.46e-07 | 20 | 116 | 4 | 25127057 | |
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 20200478 | ||
| Pubmed | HYPK coordinates degradation of polyneddylated proteins by autophagy. | 7.18e-07 | 6 | 116 | 3 | 34836490 | |
| Pubmed | Autophagy appears during the development of the mouse lower first molar. | 7.18e-07 | 6 | 116 | 3 | 23052835 | |
| Pubmed | OATL1, a novel autophagosome-resident Rab33B-GAP, regulates autophagosomal maturation. | 7.18e-07 | 6 | 116 | 3 | 21383079 | |
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 32315611 | ||
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 16303767 | ||
| Pubmed | Autophagy proteins regulate the secretory component of osteoclastic bone resorption. | 7.18e-07 | 6 | 116 | 3 | 22055344 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | HACD3 USP11 IARS1 SF3B1 MTHFD1 ZC3H4 ABCE1 DDX54 PHF10 IQGAP3 MOV10 | 7.46e-07 | 486 | 116 | 11 | 30940648 |
| Pubmed | SAMM50 acts with p62 in piecemeal basal- and OXPHOS-induced mitophagy of SAM and MICOS components. | 8.20e-07 | 22 | 116 | 4 | 34037656 | |
| Pubmed | 1.19e-06 | 24 | 116 | 4 | 22854957 | ||
| Pubmed | Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death. | 1.25e-06 | 7 | 116 | 3 | 19864026 | |
| Pubmed | 1.25e-06 | 7 | 116 | 3 | 12890687 | ||
| Pubmed | 1.25e-06 | 7 | 116 | 3 | 24668264 | ||
| Pubmed | EPRS1 HYOU1 HACD3 IARS1 NEK9 RIF1 SF3B1 MTHFD1 LRBA GCN1 TOP2B HELLS | 1.59e-06 | 638 | 116 | 12 | 33239621 | |
| Pubmed | EPRS1 HYOU1 LONP2 IARS1 HLA-DRB1 ST3GAL1 TUBGCP4 ITGAX MTHFD1 ABCE1 CSNK1G2 DDX54 OASL LRBA IL1RAP GCN1 | 1.76e-06 | 1168 | 116 | 16 | 19946888 | |
| Pubmed | 1.94e-06 | 27 | 116 | 4 | 22354992 | ||
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 1.95e-06 | 110 | 116 | 6 | 37219487 | |
| Pubmed | Phosphorylation of NBR1 by GSK3 modulates protein aggregation. | 2.00e-06 | 8 | 116 | 3 | 24879152 | |
| Pubmed | 2.00e-06 | 8 | 116 | 3 | 24290141 | ||
| Pubmed | RIPOR2-mediated autophagy dysfunction is critical for aminoglycoside-induced hearing loss. | 2.00e-06 | 8 | 116 | 3 | 36113482 | |
| Pubmed | 2.00e-06 | 8 | 116 | 3 | 30202015 | ||
| Pubmed | Murine Apg12p has a substrate preference for murine Apg7p over three Apg8p homologs. | 2.00e-06 | 8 | 116 | 3 | 11890701 | |
| Pubmed | EPRS1 USP11 IARS1 FRYL NEK9 RIF1 SF3B1 MTHFD1 ZC3H4 ALB MOV10 | 2.51e-06 | 551 | 116 | 11 | 34728620 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.99e-06 | 9 | 116 | 3 | 18394993 | |
| Pubmed | Ambra1 regulates autophagy and development of the nervous system. | 2.99e-06 | 9 | 116 | 3 | 17589504 | |
| Pubmed | 2.99e-06 | 9 | 116 | 3 | 21185285 | ||
| Pubmed | 3.45e-06 | 31 | 116 | 4 | 29099309 | ||
| Pubmed | 4.26e-06 | 10 | 116 | 3 | 31213539 | ||
| Pubmed | Cdx2 regulates endo-lysosomal function and epithelial cell polarity. | 4.46e-06 | 33 | 116 | 4 | 20551175 | |
| Pubmed | 4.46e-06 | 33 | 116 | 4 | 33436499 | ||
| Pubmed | EPRS1 HYOU1 HACD3 IARS1 ICE2 ATG2B SLC38A1 MTHFD1 ABCE1 ROBO1 LRBA GCN1 | 4.61e-06 | 708 | 116 | 12 | 39231216 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.49e-06 | 202 | 116 | 7 | 33005030 | |
| Pubmed | 5.49e-06 | 202 | 116 | 7 | 24639526 | ||
| Pubmed | Global Proximity Interactome of the Human Macroautophagy Pathway. | 5.68e-06 | 35 | 116 | 4 | 34524948 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | HYOU1 DIS3L IARS1 ICE2 ZC3H4 EIF4E GCN1 PHF10 TOP2B MOV10 AHNAK2 HELLS | 5.78e-06 | 724 | 116 | 12 | 36232890 |
| Pubmed | 5.85e-06 | 11 | 116 | 3 | 30704899 | ||
| Pubmed | 5.85e-06 | 11 | 116 | 3 | 28320871 | ||
| Pubmed | 5.85e-06 | 11 | 116 | 3 | 24089209 | ||
| Pubmed | 5.85e-06 | 11 | 116 | 3 | 25684205 | ||
| Pubmed | 5.85e-06 | 11 | 116 | 3 | 22808111 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EPRS1 HYOU1 HACD3 USP11 IARS1 GABARAP FRYL SORBS1 NEK9 SF3B1 MTHFD1 EIF4E LRBA GCN1 MOV10 HELLS | 5.86e-06 | 1284 | 116 | 16 | 17353931 |
| Pubmed | 5.86e-06 | 383 | 116 | 9 | 29331416 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | OBSCN POLRMT SORBS1 TGM5 MTHFD1 ZC3H4 DDX54 LRBA TAPBP HELLS | 6.85e-06 | 497 | 116 | 10 | 36774506 |
| Pubmed | Embryogenesis and Adult Life in the Absence of Intrinsic Apoptosis Effectors BAX, BAK, and BOK. | 7.78e-06 | 12 | 116 | 3 | 29775594 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 HYOU1 HACD3 IARS1 RIF1 SF3B1 RRP36 MTHFD1 ZC3H4 DDX54 ALB GCN1 TOP2B HELLS | 8.41e-06 | 1024 | 116 | 14 | 24711643 |
| Pubmed | EPRS1 HYOU1 HACD3 USP11 IARS1 ICE2 APBA2 POLRMT SF3B1 MTHFD1 EIF4E ARHGAP20 PHF10 PLS1 SNTB2 MOV10 | 9.53e-06 | 1335 | 116 | 16 | 29229926 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 9.86e-06 | 221 | 116 | 7 | 29991511 | |
| Pubmed | SMARCAL1 FBRSL1 SLC38A1 IL1RAPL1 ABCE1 PLCB1 C5 BSN SNTB2 AHNAK2 HELLS | 1.00e-05 | 638 | 116 | 11 | 31182584 | |
| Pubmed | 1.01e-05 | 13 | 116 | 3 | 25847297 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 19766627 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 2592019 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 23580093 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 25421500 | ||
| Pubmed | Development of LC3/GABARAP sensors containing a LIR and a hydrophobic domain to monitor autophagy. | 1.10e-05 | 2 | 116 | 2 | 28320742 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 3596674 | ||
| Interaction | RNF123 interactions | OR51A4 EPRS1 HACD3 IARS1 NEXMIF OBSCN GABARAP GABARAPL1 MTHFD1 ABCE1 CSNK1G2 EIF4E PRICKLE2 ALB MAP1LC3B ARHGAP20 PLS1 MOV10 | 1.10e-06 | 824 | 116 | 18 | int:RNF123 |
| Interaction | LRP8 interactions | 1.03e-05 | 86 | 116 | 6 | int:LRP8 | |
| Interaction | ATG4B interactions | 1.25e-05 | 134 | 116 | 7 | int:ATG4B | |
| Interaction | ANK2 interactions | 2.18e-05 | 98 | 116 | 6 | int:ANK2 | |
| Interaction | PINK1 interactions | A2M EPRS1 HYOU1 IARS1 MAP1LC3A APOH PPL SF3B1 MTHFD1 ALB MAP1LC3B GCN1 MOV10 AHNAK2 | 3.61e-05 | 679 | 116 | 14 | int:PINK1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 9.38e-05 | 415 | 116 | 7 | chr12q24 | |
| Cytoband | 3p24 | 1.75e-04 | 8 | 116 | 2 | 3p24 | |
| Cytoband | 12q24.2 | 7.42e-04 | 16 | 116 | 2 | 12q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q12 | 1.20e-03 | 82 | 116 | 3 | chr2q12 | |
| Cytoband | 12p11.21 | 1.41e-03 | 22 | 116 | 2 | 12p11.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q33 | 1.87e-03 | 205 | 116 | 4 | chr2q33 | |
| Cytoband | 15q22.2 | 2.46e-03 | 29 | 116 | 2 | 15q22.2 | |
| GeneFamily | Autophagy related | 9.70e-09 | 33 | 86 | 6 | 1022 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 4.54e-05 | 15 | 86 | 3 | 1296 | |
| GeneFamily | Topoisomerases | 3.31e-04 | 6 | 86 | 2 | 1050 | |
| GeneFamily | Complement system|Sushi domain containing | 6.62e-04 | 36 | 86 | 3 | 492 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 7.88e-04 | 9 | 86 | 2 | 1234 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.03e-03 | 161 | 86 | 5 | 593 | |
| GeneFamily | C1-set domain containing | 1.04e-03 | 42 | 86 | 3 | 591 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 1.04e-03 | 42 | 86 | 3 | 602 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 3.63e-03 | 19 | 86 | 2 | 131 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 6.25e-03 | 25 | 86 | 2 | 504 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.50e-05 | 250 | 115 | 8 | M11318 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN | 2.96e-05 | 200 | 115 | 7 | M3469 | |
| Coexpression | GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN | 2.96e-05 | 200 | 115 | 7 | M6270 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | 2.96e-05 | 200 | 115 | 7 | M7978 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-08 | 189 | 115 | 8 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.34e-07 | 185 | 115 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.54e-07 | 186 | 115 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 4.98e-06 | 168 | 115 | 6 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 4.98e-06 | 168 | 115 | 6 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.98e-06 | 168 | 115 | 6 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.09e-06 | 174 | 115 | 6 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 7.63e-06 | 181 | 115 | 6 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-Memory_B_cells|blood / Manually curated celltypes from each tissue | 8.13e-06 | 183 | 115 | 6 | e3a418b745d7f040adf47be9e1043b945cae47ed | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.19e-06 | 187 | 115 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.48e-06 | 188 | 115 | 6 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.77e-06 | 189 | 115 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.77e-06 | 189 | 115 | 6 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.77e-06 | 189 | 115 | 6 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.01e-05 | 190 | 115 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 190 | 115 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.01e-05 | 190 | 115 | 6 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.04e-05 | 191 | 115 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.04e-05 | 191 | 115 | 6 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.04e-05 | 191 | 115 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.04e-05 | 191 | 115 | 6 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 192 | 115 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 192 | 115 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.10e-05 | 193 | 115 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-05 | 193 | 115 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 194 | 115 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 195 | 115 | 6 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 196 | 115 | 6 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-05 | 196 | 115 | 6 | ff88e5b919b1be93159ad2200a7786d1c5272724 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-05 | 198 | 115 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_CTL|Int-URO / Disease, condition lineage and cell class | 1.27e-05 | 198 | 115 | 6 | 717735d755745439f97ba1b71785c73945dfa9c5 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.35e-05 | 200 | 115 | 6 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 3.39e-05 | 142 | 115 | 5 | 0e0f8bb956ff89dc98e8fa56f8acac33e01a26dd | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-05 | 144 | 115 | 5 | 75b16adfbe84f69376e6566d531ba7919d5c5192 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(2)_48hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 4.13e-05 | 148 | 115 | 5 | a061a745c09254e063411b7d835d5597a0007e29 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.54e-05 | 151 | 115 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.69e-05 | 152 | 115 | 5 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD4_CTL|Int-URO / Disease, Lineage and Cell Type | 4.84e-05 | 153 | 115 | 5 | fdc7dfa8f4db90bfdc7180bf178cf6d2dd064d97 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-05 | 156 | 115 | 5 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-05 | 156 | 115 | 5 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | lymphoid-T_cell-pro-T_cell|T_cell / Lineage, cell class and subclass | 5.98e-05 | 160 | 115 | 5 | 66fe86d2f37983761141e5bb3de127f0b4bb0951 | |
| ToppCell | Basal_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.72e-05 | 164 | 115 | 5 | b15a26130a1ea1b370b6e3be21f02a0d6aaf6b3c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 165 | 115 | 5 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Plasmablast|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 7.12e-05 | 166 | 115 | 5 | 0cc3b9681bc000a1b00d3b60f79f16eea1c2e2e1 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 7.33e-05 | 167 | 115 | 5 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Plasmablast|World / disease group, cell group and cell class (v2) | 7.33e-05 | 167 | 115 | 5 | f26ae4de4804a3486502e3df37eabf3dfca688f5 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.53e-05 | 168 | 115 | 5 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.75e-05 | 169 | 115 | 5 | 319511ea57bbd72c2d95e8516d093689df67a912 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.97e-05 | 170 | 115 | 5 | ce2fd2fbbfd152290be0cf8e513f102fdc182b41 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.97e-05 | 170 | 115 | 5 | ab5c6a91c371e4df15b0842828dc55039695ab06 | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.19e-05 | 171 | 115 | 5 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-05 | 172 | 115 | 5 | b043d4f81dced7fb3326043f68474123be47cc5d | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.65e-05 | 173 | 115 | 5 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.65e-05 | 173 | 115 | 5 | d13ae4046a25ee0fb492ddedf44583a879a432e9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.65e-05 | 173 | 115 | 5 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 8.89e-05 | 174 | 115 | 5 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 175 | 115 | 5 | 787ac1a12cda10af5c8830471702a4cbaf43e79e | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.38e-05 | 176 | 115 | 5 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.63e-05 | 177 | 115 | 5 | 345cebc19f93970a9a46be139208b300081f5493 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.63e-05 | 177 | 115 | 5 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.02e-04 | 179 | 115 | 5 | c17ae394b855f01f8ca1765c416fd8b34a96e60b | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.02e-04 | 179 | 115 | 5 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.02e-04 | 179 | 115 | 5 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | 729f0d7af573c7796d8e28e6eec3af2fc0bd33a2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | 9ef79a7c60227e352ac166c7274adb31f585f5ca | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.07e-04 | 181 | 115 | 5 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 181 | 115 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-04 | 181 | 115 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 181 | 115 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 182 | 115 | 5 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 182 | 115 | 5 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 1.10e-04 | 182 | 115 | 5 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 1.13e-04 | 183 | 115 | 5 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-04 | 184 | 115 | 5 | abb61e744a9031e0c91eb560a8f486a0ca5a01cc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 184 | 115 | 5 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 1.19e-04 | 185 | 115 | 5 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 1.19e-04 | 185 | 115 | 5 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 1.22e-04 | 186 | 115 | 5 | 5624b1fc7eab9f505588fcc86a24d14f8bcbfef7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 186 | 115 | 5 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 186 | 115 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 186 | 115 | 5 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 187 | 115 | 5 | d69f4eee0304a7db226275ab77fc9d5d2b6f3a07 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 187 | 115 | 5 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 187 | 115 | 5 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-04 | 188 | 115 | 5 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 188 | 115 | 5 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 188 | 115 | 5 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 188 | 115 | 5 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 1.28e-04 | 188 | 115 | 5 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 188 | 115 | 5 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 189 | 115 | 5 | a59025e82fabd9d60e2438dee85b2644478cc7c8 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 189 | 115 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 189 | 115 | 5 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 189 | 115 | 5 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 1.31e-04 | 189 | 115 | 5 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.31e-04 | 189 | 115 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 190 | 115 | 5 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| Disease | C5a anaphylatoxin measurement | 4.27e-05 | 3 | 112 | 2 | EFO_0020208 | |
| Disease | Bipolar Disorder | CACNB2 PDE9A RASGRF1 HLA-DRB1 HLA-DRB4 ST3GAL1 MTHFD1 PLCB1 CNR1 | 8.82e-05 | 477 | 112 | 9 | C0005586 |
| Disease | Schizophrenia | CACNB2 HLA-DRB1 APBA2 GABARAP ST3GAL1 APOH MTHFD1 PLCB1 ARC MAPK8 TAPBP CNR1 | 1.36e-04 | 883 | 112 | 12 | C0036341 |
| Disease | Nephrotic Syndrome | 1.46e-04 | 27 | 112 | 3 | C0027726 | |
| Disease | C-reactive protein measurement | SLAMF8 TDRD15 CACNB2 HLA-DRB1 APOH PPL SLC38A1 CSNK1G2 NTM OASL AACS BSN GCN1 TOP2B | 1.93e-04 | 1206 | 112 | 14 | EFO_0004458 |
| Disease | Idiopathic Membranous Glomerulonephritis | 2.12e-04 | 6 | 112 | 2 | C0086445 | |
| Disease | Heymann Nephritis | 2.12e-04 | 6 | 112 | 2 | C1704378 | |
| Disease | Angioedema | 2.12e-04 | 6 | 112 | 2 | C0002994 | |
| Disease | Membranous glomerulonephritis | 2.12e-04 | 6 | 112 | 2 | C0017665 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.75e-04 | 150 | 112 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | antiphospholipid syndrome (is_implicated_in) | 3.94e-04 | 8 | 112 | 2 | DOID:2988 (is_implicated_in) | |
| Disease | cholesteryl ester measurement | 4.56e-04 | 257 | 112 | 6 | EFO_0010351 | |
| Disease | hematocrit | TDRD15 PDE9A HLA-DRB1 FBRSL1 SORBS1 FAT1 SPPL2A CLCNKB ZC3H4 OASL PLCB1 BSN | 4.67e-04 | 1011 | 112 | 12 | EFO_0004348 |
| Disease | intermittent Staphylococcus aureus carrier status | 5.05e-04 | 9 | 112 | 2 | EFO_0007758 | |
| Disease | Antihypertensive use measurement | 5.36e-04 | 265 | 112 | 6 | EFO_0009927 | |
| Disease | heart disease (is_marker_for) | 6.30e-04 | 10 | 112 | 2 | DOID:114 (is_marker_for) | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 6.30e-04 | 10 | 112 | 2 | EFO_0008321 | |
| Disease | Paranoia | 7.68e-04 | 11 | 112 | 2 | C1456784 | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 7.68e-04 | 11 | 112 | 2 | DOID:0080822 (is_implicated_in) | |
| Disease | Pain, Migratory | 8.64e-04 | 49 | 112 | 3 | C0751407 | |
| Disease | Suffering, Physical | 8.64e-04 | 49 | 112 | 3 | C0751408 | |
| Disease | Pain, Crushing | 8.64e-04 | 49 | 112 | 3 | C0458259 | |
| Disease | Pain, Splitting | 8.64e-04 | 49 | 112 | 3 | C0458257 | |
| Disease | Pain | 8.64e-04 | 49 | 112 | 3 | C0030193 | |
| Disease | Radiating pain | 8.64e-04 | 49 | 112 | 3 | C0234254 | |
| Disease | Pain, Burning | 8.64e-04 | 49 | 112 | 3 | C0234230 | |
| Disease | Ache | 8.64e-04 | 49 | 112 | 3 | C0234238 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 8.64e-04 | 49 | 112 | 3 | EFO_0022256 | |
| Disease | cognitive inhibition measurement | 9.16e-04 | 50 | 112 | 3 | EFO_0007969 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 9.19e-04 | 12 | 112 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | abdominal aortic aneurysm (is_implicated_in) | 9.19e-04 | 12 | 112 | 2 | DOID:7693 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.04e-03 | 301 | 112 | 6 | DOID:684 (is_marker_for) | |
| Disease | age at menopause | 1.06e-03 | 302 | 112 | 6 | EFO_0004704 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 1.15e-03 | 54 | 112 | 3 | EFO_0022244 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.26e-03 | 14 | 112 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | C-C motif chemokine 19 measurement | 1.26e-03 | 14 | 112 | 2 | EFO_0008047 | |
| Disease | GDH/6PGL endoplasmic bifunctional protein measurement | 1.26e-03 | 14 | 112 | 2 | EFO_0801619 | |
| Disease | triglycerides in LDL measurement | 1.27e-03 | 56 | 112 | 3 | EFO_0022320 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 1.27e-03 | 56 | 112 | 3 | EFO_0022316 | |
| Disease | Calcium channel blocker use measurement | 1.34e-03 | 213 | 112 | 5 | EFO_0009930 | |
| Disease | triglycerides in IDL measurement | 1.41e-03 | 58 | 112 | 3 | EFO_0022149 | |
| Disease | interleukin 18 receptor 1 measurement | 1.45e-03 | 15 | 112 | 2 | EFO_0008178 | |
| Disease | Pancreatitis | 1.48e-03 | 59 | 112 | 3 | C0030305 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 1.48e-03 | 59 | 112 | 3 | EFO_0022260 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 1.48e-03 | 59 | 112 | 3 | EFO_0022289 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 1.56e-03 | 60 | 112 | 3 | EFO_0021898 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.61e-03 | 222 | 112 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | Urticaria | 1.65e-03 | 16 | 112 | 2 | C0042109 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.71e-03 | 225 | 112 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | triglycerides in medium LDL measurement | 1.71e-03 | 62 | 112 | 3 | EFO_0022322 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 1.71e-03 | 62 | 112 | 3 | EFO_0022306 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 1.71e-03 | 62 | 112 | 3 | EFO_0022263 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 1.79e-03 | 63 | 112 | 3 | EFO_0022239 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 1.79e-03 | 63 | 112 | 3 | EFO_0022292 | |
| Disease | Allergic Reaction | 1.79e-03 | 63 | 112 | 3 | C1527304 | |
| Disease | Antibody Deficiency Syndrome | 1.87e-03 | 17 | 112 | 2 | C0003257 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 1.87e-03 | 17 | 112 | 2 | EFO_0022232 | |
| Disease | Hypersensitivity | 1.87e-03 | 64 | 112 | 3 | C0020517 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 1.87e-03 | 64 | 112 | 3 | EFO_0022253 | |
| Disease | coronary artery disease | TDRD15 KHDRBS2 APOH NEK9 PDXK SLC38A1 CSNK1G2 CARF C5 DENND5A BSN ARHGAP20 | 1.95e-03 | 1194 | 112 | 12 | EFO_0001645 |
| Disease | triglycerides in small LDL measurement | 1.96e-03 | 65 | 112 | 3 | EFO_0022323 | |
| Disease | Myeloid Leukemia | 2.10e-03 | 18 | 112 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.10e-03 | 18 | 112 | 2 | C0023466 | |
| Disease | total lipids in large VLDL | 2.14e-03 | 67 | 112 | 3 | EFO_0022175 | |
| Disease | triglycerides in very small VLDL measurement | 2.23e-03 | 68 | 112 | 3 | EFO_0022144 | |
| Disease | aspartate aminotransferase measurement | CACNB2 HLA-DRB1 KHDRBS2 OBSCN ST3GAL1 APOH ROBO1 LRBA GCN1 MOV10 | 2.35e-03 | 904 | 112 | 10 | EFO_0004736 |
| Disease | serum gamma-glutamyl transferase measurement | 2.55e-03 | 914 | 112 | 10 | EFO_0004532 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.80e-03 | 153 | 112 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.80e-03 | 153 | 112 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | Lymphoma, Diffuse | 2.86e-03 | 21 | 112 | 2 | C3714542 | |
| Disease | Low Grade Lymphoma (neoplasm) | 2.86e-03 | 21 | 112 | 2 | C0079747 | |
| Disease | Lymphoma, Intermediate-Grade | 2.86e-03 | 21 | 112 | 2 | C0079741 | |
| Disease | High Grade Lymphoma (neoplasm) | 2.86e-03 | 21 | 112 | 2 | C0079740 | |
| Disease | Diffuse Mixed-Cell Lymphoma | 2.86e-03 | 21 | 112 | 2 | C0079757 | |
| Disease | Lymphoma, Undifferentiated | 2.86e-03 | 21 | 112 | 2 | C0024306 | |
| Disease | Reticulosarcoma | 2.86e-03 | 21 | 112 | 2 | C0024302 | |
| Disease | Lymphoma, Mixed-Cell | 2.86e-03 | 21 | 112 | 2 | C0024304 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 2.95e-03 | 75 | 112 | 3 | EFO_0022287 | |
| Disease | Lymphoma, Non-Hodgkin, Familial | 3.14e-03 | 22 | 112 | 2 | C4721532 | |
| Disease | Lymphoma, Small Noncleaved-Cell | 3.14e-03 | 22 | 112 | 2 | C0079770 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 3.28e-03 | 160 | 112 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Immunologic Deficiency Syndromes | 3.43e-03 | 23 | 112 | 2 | C0021051 | |
| Disease | vitronectin measurement | 3.43e-03 | 23 | 112 | 2 | EFO_0021843 | |
| Disease | Etat Marbre | 3.43e-03 | 23 | 112 | 2 | C0266487 | |
| Disease | Liver Failure, Acute | 3.73e-03 | 24 | 112 | 2 | C0162557 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPVSRIVKPQPVYEI | 191 | Q6PI77 | |
| IVKPQPVYEINEKNR | 196 | Q6PI77 | |
| QPKVSDPYRAVVKVS | 526 | Q9HCM7 | |
| LLVRYTKKVPQVSTP | 431 | P02768 | |
| VPVKKATVVYQGERV | 266 | P02749 | |
| PIVVIARVVPNYKEF | 401 | Q8N5R6 | |
| PDLKKVVVIPYVSSR | 231 | Q86V21 | |
| VKAPLQERYVEKIII | 116 | P10323 | |
| PVLERYTSVVTLVKP | 131 | Q9H8M1 | |
| IIQYVVGTLQPKLKR | 321 | Q7LC44 | |
| PVTTVLIKRPDLKYQ | 656 | Q99767 | |
| TPALEKVVPLKRIYI | 86 | A0PJW8 | |
| FPIPVIRYVVKEVSL | 1541 | Q96BY7 | |
| DVPVRDLKPAIVKVY | 1436 | P01023 | |
| PIIVYVKISSPKVLQ | 391 | Q08289 | |
| IRVKRYEKVPVILVG | 101 | P10114 | |
| VLEKYKVHNPTPLIV | 1096 | P20702 | |
| QHPTKIPVIIERYKG | 26 | Q9GZQ8 | |
| IPVIIERYKGEKQLP | 31 | Q9GZQ8 | |
| KAVVKEVLRLYPVVP | 371 | O15528 | |
| PSKESVVLVYVKILP | 2681 | Q14517 | |
| IVQLYVAPAPEKSRK | 251 | Q96NT5 | |
| VALEVPPKREVVVYA | 456 | Q9NRZ9 | |
| IYIKIPQVPLCVSYK | 2116 | Q14667 | |
| VQVLKEKPYPIAEVE | 111 | Q86WA8 | |
| YTPQKVDVPKALIIV | 521 | Q8TD19 | |
| KPEPVYKLTQRQVNI | 66 | Q9P035 | |
| NPRIPYTEFSVIIKK | 651 | Q92831 | |
| VVRRVKVTVNYPPYI | 211 | Q9P121 | |
| RELYVPRIASKPIIV | 161 | Q9Y217 | |
| KVKQKVPAPRYTVEL | 346 | Q9NPH3 | |
| RVYKERLGLPPKIVI | 181 | P06730 | |
| YVAIKLEPIKSRAPQ | 71 | P78368 | |
| PKVEIVRYISAPEKT | 2696 | Q9UPA5 | |
| IKKVQKFPEYRVPTD | 321 | Q8N187 | |
| YKVPTPIQRKTIPVI | 116 | Q8TDD1 | |
| VTVPNLKPLTVYCVK | 391 | P17181 | |
| IVRVIPSYPKILKVI | 226 | Q96MA6 | |
| PLPGYKVREIVEKIL | 46 | Q14651 | |
| IDIKKYQVLVGEPVR | 36 | Q9NZN1 | |
| KLQPTVRTYVENRPK | 251 | P45983 | |
| QQVVPLKYRRETPLK | 386 | O60437 | |
| SERTPYKVRPVAIKQ | 71 | O76083 | |
| EPSLLPYVKKVIVYL | 1416 | O94915 | |
| PEKVIVKTRTEYQPE | 41 | Q9Y328 | |
| ATVKKVVNYLPRVGV | 2171 | P50851 | |
| IRKKYPDRVPVIVEK | 21 | O95166 | |
| VEILPSYIPVRVAEK | 261 | Q9UGJ1 | |
| IKSRVVLPYLVPKLT | 2071 | Q92616 | |
| PLTNPIVYCVKTKQI | 286 | Q8NGJ6 | |
| KRYVLPKFEVTVNAP | 201 | Q6IE36 | |
| PLKPRISITKGVIYI | 176 | Q9NYM4 | |
| APSVVPLKKIYDVEQ | 76 | Q86VI3 | |
| TTERKYNLKVHVPPV | 1346 | Q96RW7 | |
| FNLIVNPYEPIRKVK | 366 | Q15646 | |
| KILVQVPPRFVNKVR | 6101 | Q5VST9 | |
| VPYVNSPGEKLRIKQ | 61 | Q7Z3G6 | |
| PQGKYKVLPTERTKV | 236 | Q8WUB8 | |
| VPKIIYPKNHSIEVQ | 226 | Q9HB29 | |
| YLIAFQVPRPKIKLI | 321 | A6NKT7 | |
| AIIKPQYVDQIPKAA | 166 | P61221 | |
| KVKPFVVRDAVVYPI | 431 | Q9Y4L1 | |
| KKIRRQFPVYVLPKV | 761 | Q659A1 | |
| PGYAKVIKKVIIPAR | 556 | Q66K79 | |
| IRKKYPDRVPVIVEK | 21 | Q9H0R8 | |
| TIRLEIISNKPYKIP | 966 | Q8TF46 | |
| PETPYLRKHKVIFVV | 2071 | A8TX70 | |
| DKPVYTPDQSVKVRV | 131 | P01031 | |
| FRIRPVTPVEKYIKV | 71 | Q9H1P6 | |
| IPYRSVIIPIKKLSN | 936 | Q6ZUT9 | |
| QRRVQPKVTVYPSKT | 121 | P01911 | |
| PLAYKRIVTRPKAVV | 221 | P21554 | |
| TILIPYHILIVPSKK | 951 | Q6IQ26 | |
| QRRVQPKVTVYPSKT | 121 | P13762 | |
| RPEPQLKGIVTKLYS | 61 | Q92913 | |
| SERVLIPVKQYPKFN | 61 | Q5VWX1 | |
| EKYKREKAIQIVTPP | 186 | Q92851 | |
| PKQSSRVPLYIKVLD | 466 | P55285 | |
| RKVVKPVEILNYIIP | 346 | Q9NYL5 | |
| VPVIQPYRLDSKVKQ | 1076 | O00411 | |
| PVEDKIRIIAQKIYG | 821 | P11586 | |
| VQYNPAIIKVKVEPL | 456 | P07358 | |
| PIIYGVKTKQIRESI | 291 | Q8NGK3 | |
| VVRFPVLILEPTKIY | 556 | Q99683 | |
| ESKPVNILVYTKIPL | 656 | Q9P2F6 | |
| YLIAFQVPRPKIKLI | 321 | Q7Z3J3 | |
| IVPYPRKITLIKQLA | 296 | O15034 | |
| SVAIPKASRVKPVEY | 171 | Q9NX07 | |
| NKKVIDPVAPRYVAL | 496 | P07814 | |
| RYVALLKKEVIPVNV | 506 | P07814 | |
| IPVVEHKVEKVYVPA | 146 | Q02880 | |
| VVPKFKLSYIQPRTQ | 76 | Q8N9U0 | |
| VINKPSPVTYSERKI | 1181 | B5MCY1 | |
| SVGVISPYRKQVEKI | 826 | Q9HCE1 | |
| VYPEELKPVLTQAKQ | 946 | Q5UIP0 | |
| VTRKEPPVIIKYIII | 531 | Q5QGS0 | |
| PPVIIKYIIINRFKG | 536 | Q5QGS0 | |
| RPAELYTQIIAVKPT | 586 | Q9NZC9 | |
| ISHTYIPVPAKIRVK | 226 | Q11201 | |
| IPIKYPLKEIVVIHQ | 841 | P41252 | |
| IPVIIERYKGEKQLP | 31 | Q9H492 | |
| LITIYKKPISAIPAR | 691 | Q13972 | |
| YKEKVVPLADIITPN | 136 | O00764 | |
| LKVKIPEPHTQARVY | 5521 | Q8IVF2 | |
| DGTVIVKKLPYLPRI | 521 | P51801 | |
| LEREKPQTKILYITP | 116 | O94762 | |
| QHPTKIPVIIERYKG | 26 | A6NCE7 | |
| IPVIIERYKGEKQLP | 31 | A6NCE7 | |
| TVVNALGKRVKPYLP | 916 | O75533 | |
| QVTLELAVYKPPKVS | 281 | O15533 | |
| KIPKDYVVQVIVSQP | 211 | Q8WUN7 | |
| EKLPVVIRVPKLIYF | 381 | Q8TCT8 | |
| TYVDVIKRPLVKNPV | 921 | Q9BX66 | |
| RVPVEKPVYKNLQLF | 376 | Q969P6 | |
| IRVPFLRQVVPISKK | 101 | Q96EU6 | |
| VVIPDLRKGVNYEIK | 736 | Q9Y6N7 | |
| TLQLKVYDAVPRPVV | 116 | Q9P0V8 | |
| PEKILVNKIITLSYP | 606 | O43548 | |
| YTKLKLQVTPEGRIP | 156 | Q9NQ66 | |
| SYKVQPVAIVRPLER | 56 | Q658L1 | |
| YNKKIPSLFEIVVRP | 576 | Q9UPT8 | |
| FIREVTPYIKKPSLV | 196 | Q13425 | |
| RKVIELPNIQKVEVY | 181 | P51784 | |
| VIYKKFQIPCIVPEL | 236 | Q9H2H9 |